Catalyst Wire Dossier Catalyst Wire Dossier

Lesigercept

Lesigercept · Yuhan Corporation
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Lesigercept, covering 2026-04-15 to 2026-04-15. Get the full timeline:

Most recent: Clinical Trial Update: Phase 2 Study of Lesigercept in Adult Patients With Chronic Spontaneous Urticaria Who Are Inadequately Controlled by H1-Antihistamines [Phase 2]

See pricing